Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves’ Disease
Authors:
Open Access
- 30 July 2019
- journal article
- research article
- Published by Journal of the ASEAN Federation of Endocrine Societies (JAFES) in Journal of the ASEAN Federation of Endocrine Societies
- Vol. 34 (1) , 99-102
Abstract
Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves’ DiseaseKeywords
This publication has 23 references indexed in Scilit:
- Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drugBlood, 2014
- Mechanisms of methimazole cytotoxicity in isolated rat hepatocytesDrug and Chemical Toxicology, 2012
- Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical EndocrinologistsThyroid®, 2011
- Antithyroid Drug-Induced Aplastic AnemiaThyroid®, 2008
- Concomitant Agranulocytosis and Hepatotoxicity After Treatment with CarbimazoleAnnals of Pharmacotherapy, 2006
- Antithyroid DrugsNew England Journal of Medicine, 2005
- Methimazole-Induced Severe Aplastic Anemia: Unsuccessful Treatment with Recombinant Human Granulocyte-Monocyte Colony-Stimulating FactorThyroid®, 1997
- Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF)Annals of Hematology, 1993
- Aplastic Anemia Associated with Antithyroid DrugsThe American Journal of the Medical Sciences, 1991
- Agranulocytosis Associated with Antithyroid DrugsAnnals of Internal Medicine, 1983